FAST vs STRO
Fastenal Company (FAST) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. STRO currently screens at market cap $470.8M.
Not investment advice. Open the FAST and STRO stock pages for the full models.
Not investment advice.